Back to Trades
Bumpus Namandje
DirectorCIK 0002060594
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 2
- Buy transactions
- 0
- Sell transactions
- 2
- Companies
- 1
- Active
- 2026
Bumpus Namandje, Director, has filed 2 SEC reports (2026), all concentrated in RECURSION PHARMACEUTICALS, INC. (RXRX), totaling $28.1K in disclosed volume. Weighing $0 bought versus $28.1K sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
2 loaded
| Jun 22 | RXRX RECURSION PHARMACEUTICALS, INC. | Bumpus Namandje | Director | Sell | $12.6K |
| Jun 4 | RXRX RECURSION PHARMACEUTICALS, INC. | Bumpus Namandje | Director | Sell | $15.5K |
2 filings